Bessler H, Levental Z, Karp L, Modai I, Djaldetti M, Weizman A
Hematology Research Laboratory, Hasharon Hospital Golda Medical Center, Petah-Tikva, Israel.
Biol Psychiatry. 1995 Sep 1;38(5):297-302. doi: 10.1016/0006-3223(94)00299-I.
A line of evidence indicates changes of the immune system in schizophrenic patients. We investigated the production of cytokines by peripheral blood mononuclear cells (PBMCs) in drug-free and neuroleptic-treated schizophrenic patients compared to healthy, normal controls. A significant reduction in interleukin (IL)-2 production was detected in untreated schizophrenic patients (-59.6%; p < .05) as well as in IL-3-like activity (IL-3-LA) production (-27.4%; p < .05) in treated patients compared to controls. No alteration was observed in IL-1 beta production. It seems that schizophrenia is associated with diminished IL-2 production, while neuroleptic treatment interferes with the capacity of immunocompetent cells to synthesize and/or release Il-3-LA. The alteration in cytokine production did not correlate with either the severity of the disorder or the serum prolactin levels.
一系列证据表明精神分裂症患者的免疫系统发生了变化。我们研究了未服用药物和接受抗精神病药物治疗的精神分裂症患者外周血单个核细胞(PBMC)产生细胞因子的情况,并与健康的正常对照组进行了比较。与对照组相比,未治疗的精神分裂症患者白细胞介素(IL)-2的产生显著减少(-59.6%;p < 0.05),接受治疗的患者IL-3样活性(IL-3-LA)的产生也显著减少(-27.4%;p < 0.05)。未观察到IL-1β产生的改变。似乎精神分裂症与IL-2产生减少有关,而抗精神病药物治疗会干扰免疫活性细胞合成和/或释放IL-3-LA的能力。细胞因子产生的改变与疾病的严重程度或血清催乳素水平均无相关性。